Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...

Alex Hacopian, MD, highlights how a recent ambispective study demonstrated strong visual acuity outcomes and patient ...

Kaplan-Meier analysis showed a statistically significant difference in overall survival favoring immediate treatment (log-rank p = 0.002), though recurrence-free survival did not differ significantly ...